Inovio » About Us » Leadership » Biography

"Vaccines are among the greatest achievements of biomedical science and public health, stimulating protective immune responses against acute and chronic infectious diseases, as well as some infectious diseases that result in cancer."

Historical Comparisons of Morbidity and Mortality for Vaccine-Preventable Diseases in the United States
Journal of the American Medical Association
November, 2007

"I have stated in public seminars that, in my opinion, electroporation is the gold standard for DNA vaccine delivery, giving us the best result in terms of immunogenicity of DNA vaccines."

George N. Pavlakis, MD, PhD
Chief
Human Retrovirus Section, Vaccine Branch
National Cancer Institute

home » about us » leadership »keith wells

Biography

Keith H. Wells, Ph.D.
Senior Consultant, Biologics Consulting Group, Inc.

KEITH WELLS has 20 years of broad based experience in product development of vaccines and complex biologics, including process development, validation, manufacturing operations, and U.S. and European regulatory strategy. He has directed vaccine development at Acambis, PLC, Oravax, and The Salk Institute, and provided R&D support to vaccine manufacturing at Merck & Co. Dr. Wells has a Bachelor of Arts (cum laude) in Microbiology, University of Texas at Austin, and a Ph.D. in Microbiology and Immunology, State University of New York Health Science Center at Syracuse.